• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

a year ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

David Schwartz Clarifies His Position on XRP Holdings

chest

Former Ripple CTO David Schwartz clarified that his primary exposure to the cryptocurrency sector is now through Ripple stock rather than XRP, having significantly reduced his XRP holdings.

user avatarAyman Ben Youssef

Crypto Analyst Predicts BNB Price Could Reach $12,000

chest

Crypto analyst Crypto Patel predicts BNB price could reach $12,000 based on technical analysis and developments in the BNB Chain.

user avatarTando Nkube

Apple Achieves Record Revenue with Strong iPhone Sales

chest

Apple reports record revenue for the March quarter, driven by a 21% increase in iPhone sales to $57 billion and a 16% growth in services revenue to $31 billion.

user avatarKofi Adjeman

Bank of America Increases Apple Stock Price Target to $330

chest

Bank of America has raised its price target for Apple stock from $325 to $330, maintaining a Buy rating after the company reported its best March quarter on record.

user avatarNguyen Van Long

Franklin Templeton Partners with Ondo Finance for Blockchain Access

chest

Franklin Templeton has partnered with Ondo Finance to enable blockchain access for trading ETFs directly from crypto wallets, removing traditional investment barriers.

user avatarSatoshi Nakamura

GSR Welcomes SC Ventures as Its First External Shareholder

chest

GSR has announced that SC Ventures has become its first external shareholder, marking a significant milestone in the company's history.

user avatarJesper Sørensen

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.